Aspial Corporation Limited (A30) said on Dec, 24 2025 that it has entered into various interested person transactions (IPTs) amounting to about 25.054 million Singapore dollars for the financial year ending Dec, 31 2025.

The group’s board detailed dealings with entities linked to directors and controlling shareholders, noting that, for aggregation purposes under Singapore Exchange rules, all counterparts are treated as the same interested persons. The combined value of the IPTs represents roughly 4.95 per cent of Aspial’s latest audited net tangible assets of 506.528 million Singapore dollars as at Dec, 31 2024—below the 5 per cent threshold that would trigger mandatory shareholder approval.

Key transactions include: • A 900,000-Singapore-dollar cash injection by Aspial for a 60 per cent stake in newly formed Maxi Capital Wealth Holding, a joint venture with Maxi-Cash Capital Management (MCCM). • Maxi Capital Wealth Holding’s acquisition of Maxi Capital Financial from MCCM for 1.5 million Singapore dollars. • A proposed 15.878 million-Singapore-dollar purchase of all issued shares in AF Global that are not already held by Aspial or director-shareholder Koh Wee Meng. • Corporate charges between Aspial and AF Global (0.452 million Singapore dollars) and Aspial Lifestyle (2.4 million Singapore dollars). • A 760,000-Singapore-dollar interest-free loan to Kensington Village, a joint venture with Fragrance Group.

After excluding the joint-venture loan and equity subscription—both exempted under Listing Manual Rules 916(2) and 916(3)—the relevant IPTs total 23.231 million Singapore dollars, or 4.59 per cent of group NTA, keeping them below the shareholder-approval threshold.

Aspial’s audit committee said the terms of the transactions are on normal commercial terms and are not prejudicial to minority shareholders. No other directors or substantial shareholders, apart from the named interested parties, hold any stake in these transactions.